Seminars & Events
Monday, February 11, 2013: Dr. Daphne Soares (University of Maryland College Park) will speak on "The Sensory World of Cavefishes" at 4:45 pm in Goodpaster Hall 195.
Monday, March 4, 2013: Dr. Joe Cheer (University of Maryland Baltimore) will speak on "Endogenous Cannabinoids and the Pursuit of Reward" at 4:45 pm in Goodpaster Hall 195.
Friday, April 12, 2013: Dr. Jill McGaughy (University of New Hampshire) will speak on "The Role of Cortical Norepinephrine in the Ontogeny of Executive Function" at 3:00 pm in Schaefer Hall 106.
Alumni Highlight
Dr. Erin Johnson '02 recently received her Ph.D. in Neuroscience from the University of Rochester School of Medicine, and was inducted as an alumni member of Nu Rho Psi.
SMP Spotlight
Ron Saul, "Chronic activation of the substantia nigra nociceptin/orphanin receptor induces motor deficits similar to Parkinson's disease," 2008. Saul, the 2008 winner of the Neuroscience Award, infused a drug into the substantia nigra of rats and measured the resulting motor behaviors, mood disturbances, and cognitive abilities.
Bailey, A.M., Enos, J., and Medley, V. (2009, October). Damage to nucleus basalis magnocellularis (nBM) cholinergic target areas produce different effects on the acquisition of learning set. Poster presented at the Society for Neuroscience Annual Meeting, Chicago, IL.
Abstract
Lesions to the nucleus basalis magnocellularis (nBM) using either quisqualic acid or 192 IgG-saporin produce differing effects on the acquisition of learning set. Specifically, quisqualic acid lesions produce severe and long lasting impairments but 192 IgG-saporin lesions produce transient effects on learning set acquisition. One possible explanation for acquisition differences involves altered neuronal activity in the cholinergic target areas of the nBM. We examined two main cholinergic targets of the nBM, namely the amygdala and the prefrontal cortex (PFC). Rats with either NMDA (20 µg/µl) lesions to the basolateral amygdala (n=10) or NMDA (20 µg/µl) lesions to the anterior cingulate PFC (n=6) were tested on an olfactory learning set formation task as well as operant delayed non-matching to-position (DNMTP) and open field activity. The rats with amygdala lesions were additionally tested on a fear conditioning task. Lesions to the PFC significantly impaired acquisition of learning set as measured by chance performance on Trial 2 (M = 56.17%, SD = 7.47). Rats with PFC lesions did not differ from sham animals on the DNMTP task (p > .05) or in activity counts in an open field (p > .05). However, rats with NMDA lesions to the amygdala were significantly higher than chance (50% correct) on Trial 2 (p .05) or percentage correct on the DNMTP task (p > .05). NMDA lesions to the amygdala did, however, significantly decrease time spent freezing to an aversive CS+ in the fear conditioning task (p < .05). In total, the results imply that learning set acquisition differences following either quisqualic acid or 192 IgG-saporin lesions to the nBM are not likely due to damage to the cholinergic projection to the amygdala but may be associated with altered PFC activity.
